Dressings in Colorado

GelSana Therapeutics develops proprietary zwitterionic wound dressing technology designed to modulate overactive inflammation and support the body's natural wound healing process. The company's flagship product, CleraFlex™, is a stretchable zwitterionic wound dressing indicated for chronic wounds, surgical wounds, and burn injuries. CleraFlex features alternating positive and negative charges that create a protective barrier, calm inflammation, support healthy blood flow, balance moisture levels, and inhibit bacterial adhesion. GelSana targets high-burden chronic wound categories including diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure ulcers (PUs), surgical site infections, and acute burns. The company positions its technology as a primary wound dressing capable of replacing most conventional dressing options. GelSana's zwitterionic platform is backed by clinical and scientific validation, addressing wound care applications representing approximately $44 billion in annual U.S. healthcare costs across targeted indications.

Gamamed Vascular Systems Inc. is a medical device and consumables manufacturer specializing in vascular access solutions for hospitals, clinics, and healthcare centers worldwide. The company's product portfolio encompasses intravenous catheters, advanced central venous access systems, interventional cardiology devices, and wound dressing products. Gamamed's clinical expertise is applied across four primary areas: central venous access, interventional cardiology, IV therapy, and wound care. The company positions itself as a provider of high-performance vascular solutions driven by clinical insight and extensive experience. Products are designed to support critical care, interventional procedures, and standard IV access workflows. Gamamed serves the global healthcare market with an emphasis on quality consumable and device solutions for vascular procedures and therapies.